Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novel HDAC Inhibitor Hits Main Goal in Unresectable Melanoma Trial

(MedPage Today) -- Progression-free survival (PFS) in unresectable melanoma improved significantly with the addition of an investigational histone deacetylase (HDAC) inhibitor to immunotherapy, a randomized trial showed. Median PFS increased from...

Novel HDAC Inhibitor Hits Main Goal in Unresectable Melanoma Trial

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Are coronary stents necessary?

There is a crucial distinction between stenting as a life-saving measure to medical treatment via stenting because a narrowing of blood vessels is seen on an angiogram

More from Tuesday 27 October →